All In Biotech

Drug Trial Radar · NCT00269542

Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months

Last checked: Nov 19, 2026Latest source record: Jul 1, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 94,359 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

94,359

Actual

Start

Feb 2002

Primary completion

Mar 2003

Study completion Aug 2003

Sponsor

Lead sponsor
Society for Applied StudiesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
World Health Organization; All India Institute of Medical Sciences
First posted
Dec 23, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 1 month, up to 35 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Children, aged 1 months to 23 months, in the intervention households received zinc, iron and folic acid and those in the control households were administered iron and folic acid (IFA) alone for a period of one year. The primary outcomes were hospitalizations and deaths during this period.

Conditions

  • Morbidity
  • Mortality
  • Diarrhea
  • Pneumonia

Interventions

  • Zinc and iron folic acid - InterventionDrug

    The intervention group tablet contained 10 mg of elemental zinc, 12.5 mg of iron and 50 micrograms of folic acid.

  • Iron Folic Acid alone - PlaceboDrug

    The control group tablets were similar in composition, appearance and taste except it contained placebo for zinc.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. - to determine the impact of daily oral supplementation of zinc (5 mg per day to infants aged less than 6 months and 10 mg per day to older children) and iron folic acid to children aged 1-23 months for a period of upto 12 months on all-cause mortality,Time frame: 3 monthly home visits
  2. - to determine the impact of daily oral supplementation of zinc and iron folic acid to children 1-23 months for a period of upto 12 months on overall and diarrhea and pneumonia specific hospital admissions.Time frame: 3 monthly home visits

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.